SHELTON, CONNECTICUT / ACCESS Newswire / November 10, 2025 / NanoViricides, Inc. (NYSE American:NNVC) (the “Company”) today reported that it has received approval to Start Phase II Clinical Trial of ...

Concord sold roughly 25,000 copies and received bad to average reviews, prompting Sony to shut it down and giving the game one of the shortest lifespans ...

Apple’s updated App Review Guidelines require apps to disclose and get consent before sharing personal data with third-party ...